Diabetes drug faces bans as heart attack risk reviewed

by on 10/07/10 at 2:44 pm

LONDON: The popular diabetes drug Avandia is facing withdrawal from sale in Europe and the US after research linked it to a higher risk of heart problems, strokes and deaths in older adults.

Read more.

Leave a Reply